Search results for "Sodium"

showing 10 items of 1605 documents

Complications following an accidental sodium hypochlorite extrusion: A report of two cases

2012

Sodium hypochlorite (NaOCl) is the most commonly used solution in root canal treatments, as it is a low-cost method that displays a very effective antimicrobial activity against microbiota of infected root canals. However, this solution can cause complications especially due to its cytotoxic features. When this solution is injected into the adjacent tissues, the patient usually experiences intense pain, and an urgent treatment should be implemented in order to prevent a long-term sequelae. This paper describes the clinical features of two patients that experienced an accidental extrusion of NaOCl after endodontic treatment of varying severity and with different treatments. Furthermore, it s…

medicine.medical_specialtyTreatment protocolbusiness.industryRoot canalOdontologíaCase Report:CIENCIAS MÉDICAS [UNESCO]AntimicrobialCiencias de la saludSurgeryEndodonticschemistry.chemical_compoundmedicine.anatomical_structurechemistryAccidentalSodium hypochloriteClinical and Experimental DentistryUNESCO::CIENCIAS MÉDICASmedicineEndodònciabusinessGeneral Dentistry
researchProduct

The effect of passive ultrasonic activation of 2% chlorhexidine or 3% sodium hypochlorite in canal wall cleaning.

2014

Objectives: the purpose of this study was to compare debris removal and open tubules effectiveness of sodium hypochlorite (NaOCl) and chlorhexidine (CHX) applied as final irrigation in different protocols Study Design: sixty extracted premolars were divided into six groups according to the final irrigation technique: A and B 3 % NaOCl or 2 % CHX with the Miraject needle and no agitation; C and D, passive ultrasonic irrigation (PUI) with Irrisafe 20 tips and 3 % NaOCl or 2 % CHX; E and F, PUI with Irrisafe 25 tips and 3 % NaOCl or 2% CHX. The remaining dentine debris and opened tubules were evaluated by SEM at three root levels by two blinded investigators. The Kruskal Wallis and the Mann-Wh…

medicine.medical_specialtyUltrasonic irrigationChemistrybusiness.industryResearchChlorhexidineIrrigation techniqueDentistrySurgeryOperative Dentistry and Endodonticschemistry.chemical_compoundSodium hypochloritemedicineCanal wallbusinessGeneral Dentistrymedicine.drugJournal of clinical and experimental dentistry
researchProduct

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion

2011

Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To assess the efficacy of intravitreal Pegaptanib sodium (Macugen®) injection in the management of refractory macular edema secondary to branch retinal vein occlusion.Methods: This is a prospective, nonrandomized, interventional case series. Five eyes of five patients with macular edema refractory to either bevacizumab or triamcinolone were treated with intravitreal injection of Pegaptanib s…

medicine.medical_specialtyVisual acuityRetinal VeinTriamcinolone acetonideBevacizumabgenetic structuresBCVAPegaptanibCase Reportpegaptanib sodiumOphthalmologymedicinePegaptanib SodiumMacular edemaBRVObusiness.industryClinical OphthalmologyRE1-994medicine.diseaseeye diseasesSurgeryOphthalmologyMacugen®Branch retinal vein occlusionsense organsmedicine.symptombusinessmedicine.drug
researchProduct

Intravitreal Pegaptanib in Ischemic CRVO Refractory Exudative Macular Detachment

2012

Abstract Recent literature data reported evidence of the visual and/or anatomical benefits of all clinically available anti-VEGF drugs for the treatment of macular edema (ME) following Central Retinal Vein Occlusion (CRVO), up to 1-year followup. There are no randomized clinical trial data on anti-VEGF agents in ischemic CRVO-ME and the use of anti-VEGF agents to treat this condition. A 73-year old caucasian man, with a medical history of diabetes and systemic hypertension and an ophthalmic history of ischemic CRVO with cystoid macular edema was referred to our division on January 2011. The ophthalmic examination showed in right eye a visual acuity of 20/2000, a C2N1 cataract and an exudati…

medicine.medical_specialtyVisual acuitygenetic structuresPegaptanibIntravitreal pegaptanibCentral retinal vein occlusionOphthalmologymedicinePegaptanib SodiumExudative macular detachment; Central retinal vein occlusion; Intravitreal pegaptanibMedical historyMacular edemamedicine.diagnostic_testSettore MED/30 - Malattie Apparato Visivobusiness.industryCentral retinal vein occlusionExudative macular detachmentmedicine.diseaseFluorescein angiographyeye diseasesSurgerysense organsmedicine.symptomRanibizumabbusinessmedicine.drugJournal of Clinical & Experimental Ophthalmology
researchProduct

Management of macular edema due to branch retinal vein occlusion with intravitreal injections of pegaptanib sodium

2009

Purpose To evaluate the efficacy of Pegaptanib Sodium as single therapy for macular edema due to non-ischemic branch retinal vein occlusion. Methods In this uncontrolled prospective pilot study 17 patients have been included with non-ischemic branch retinal vein occlusion. All of them showed macular edema in the OCT with central foveal thickness higher than 350 microns (mean, 541 +/- 140) and decrease in visual acuity lower than 0,5 Snellen ETDRS charts notation (mean, 0,16+/-0,14). After an initial injection of Pegaptanib Sodium evaluations were programmed every 5 weeks and further retreatments were developed in cases with macular thickness higher than 300 microns. No other therapies were …

medicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryFoveal thicknessGeneral Medicinemedicine.diseaseeye diseasesSurgeryOphthalmologyPegaptanib SodiumMedicineBranch retinal vein occlusionsense organsmedicine.symptombusinessMacular edemaActa Ophthalmologica
researchProduct

Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus

2010

Background  One of the major goals of pemphigus therapy is to reduce the patient’s cumulative exposure to systemic corticosteroids. To investigate the efficacy of enteric-coated mycophenolate sodium (EC-MPS), 10 patients with active, refractory pemphigus vulgaris (PV) or foliaceous (PF) were treated with EC-MPS (1440 mg daily) and prednisone (75 mg daily) over 18 months. Observations  Following EC-MPS/prednisone therapy, disease progression was inhibited between days 30 and 45 in 9/10 patients (8 PV; 1 PF). At 18 months, 8/9 PV patients had clinically quiescent disease; EC-MPS therapy was no longer required in two patients as a result of disease remission. The remaining PV patient showed no…

medicine.medical_specialtybusiness.industryPemphigus vulgarisMycophenolate SodiumAzathioprineDermatologymedicine.diseaseGastroenterologySurgeryPemphigusRefractoryPrednisoneInternal medicinemedicineAdjuvant therapyAdverse effectbusinessmedicine.drugInternational Journal of Dermatology
researchProduct

The effect of the calibre and length of needle on the stability of sclerosing foam.

2020

Objectives Little is known how calibre and length of needles affect the stability of sclerosing foam. Methods Foams were made of 0.5%, 1%, 2% and 3% polidocanol, and 0.2%, 0.5%, 1% and 3% sodium tetradecyl sulfate (STS), which were mixed with air in the proportion of 4:1. These foams were ejected through needles with the length of: 4 mm, 6 mm and 13 mm, and diameter of: 0.26 mm, 0.3 mm and 0.4 mm. Results Foams made of more concentrated polidocanol were more stable. Regarding STS an opposite relationship was revealed. Foams made of polidocanol were more stable if ejected through a longer needle, while the length of needle did not significantly affect stability of STS foams. Foams ejected th…

medicine.medical_specialtybusiness.industrySodiumPolidocanolchemistry.chemical_elementGeneral Medicine030204 cardiovascular system & hematologyGastroenterologySclerosing SolutionsPolyethylene GlycolsPolidocanolSodium Tetradecyl Sulfate030207 dermatology & venereal diseases03 medical and health sciencesFoam sclerotherapy; adverse events; needles0302 clinical medicinechemistryNeedlesInternal medicineSclerotherapymedicineHumansCardiology and Cardiovascular Medicinebusinessmedicine.drugPhlebology
researchProduct

A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity

2012

Objective: Dentinal hypersensitivity is a commonly encountered problem with varied treatment options for its management. A large number of home use products have been tested and used for the management of dentinal hypersensitivity. This 8 week clinical trial investigates the temporal efficacy of commercially available calcium sodium phosphosilicate containing toothpaste in comparison to a potassium nitrate containing toothpaste. Methods: A total 20 subjects between the ages of 18 to 65 years were screened for a visual analogue score (VAS) for sensitivity of 5 or more by testing with a cold stimulus and randomly divided into test and positive control groups. Baseline sensitivity VAS scores t…

medicine.medical_specialtybusiness.product_categoryCalcium/SodiumPositive controlOdontologíaClinical studychemistry.chemical_compoundmedicineDentifricePeriodontologyGeneral DentistryToothpastebusiness.industryResearchSignificant differencePotassium nitrate:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgerychemistryAnesthesiaUNESCO::CIENCIAS MÉDICASDentin hypersensitivitybusinessJournal of Clinical and Experimental Dentistry
researchProduct

Blood pressure in chronic kidney disease stage 5D—report from a Kidney Disease: Improving Global Outcomes controversies conference

2010

Management of blood pressure (BP) in patients with chronic kidney disease receiving dialysis (stage 5D) provides a significant challenge for healthcare professionals. The association between BP and cardiovascular disease risk has been well studied in the general population; however, in dialysis patients, physiological and dialysis-related mechanisms influencing BP are complex, and the associated risk is poorly understood. In stage 5D, BP is determined by the complex interplay of fluid volume and prescription of post-dialysis target weight, sodium load, the renin–angiotensin and sympathetic nervous systems, and diverse exogenous factors, such as administration of erythropoiesis-stimulating a…

medicine.medical_specialtyhypotensionhypertensionmedicine.medical_treatmentPopulationLeft ventricular hypertrophylaw.inventionRandomized controlled triallawMedicineantihypertensiveMedical prescriptioneducationIntensive care medicinesodium managementDialysiseducation.field_of_studybusiness.industryGuidelinemedicine.diseaseBlood pressureNephrologydialysisbusinesschronic kidney diseaseKidney diseaseKidney International
researchProduct

Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema.

1997

Abstract Purpose: To compare the efficacy and tolerance of diclofenac 0.1 % eyedrops with a regimen that included a brief course of steroids in the treatment of postoperative inflammation after extracapsular cataract surgery and posterior chamber intraocular lens implantation. A second objective was to compare the efficacy of diclofenac 0.1% eyedrops in the same patients and control group in preventing cystoid macular edema (CME). Setting: Eight university/hospital centers and one company in Italy. Methods: The multicenter, controlled, randomized, prospective, double-blind study included 281 patients. All were evaluated at baseline, at surgery, and after 1, 5, 36, 67, and 140 days. Postoper…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentInflammationDiclofenac SodiumCataract surgerymedicine.diseaseFluorescein angiographySensory SystemsSurgeryOphthalmologyRegimenDiclofenacAnesthesiaRelative riskMedicineSurgerymedicine.symptombusinessMacular edemamedicine.drug
researchProduct